Loading…

Complete response at first chemoembolization is still the most robust predictor for favorable outcome in hepatocellular carcinoma

Backgrounds & Aims The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses. Met...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2015-06, Vol.62 (6), p.1304-1310
Main Authors: Kim, Beom Kyung, Kim, Seung Up, Kim, Kyung Ah, Chung, Yong Eun, Kim, Myeong-Jin, Park, Mi-Suk, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Man Deuk, Park, Sung Il, Won, Jong Yoon, Lee, Do Yun, Han, Kwang-Hyub
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Backgrounds & Aims The aim of this study is to evaluate the prognostic significances of not only the initial and the best response during repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC), but if eligible, also the time point of achieving treatment responses. Methods Three hundred and fourteen treatment-naïve patients with well-preserved liver function undergoing TACE were recruited. Treatment responses were assessed using modified Response Evaluation Criteria in Solid Tumors. Overall survival (OS) was analyzed using Kaplan–Meier methods, and Cox regression analysis was performed for multivariate analysis. Results After adjusting other variables, objective response (complete response [CR] and partial response [PR]) as the initial response (adjusted hazard ratio [HR] 0.410) and the best response (adjusted HR 0.335) had independent prognostic significances for OS, respectively (both p
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2015.01.022